BDBM350532 N-(4-bromophenyl)-2-(2,4-dioxo-1,3- diazaspiro[4.6]undec-3-yl)acetamide::US10208071, Table 3.8::US10799518, Structure TABLE 3.8

SMILES Brc1ccc(NC(=O)CN2C(=O)NC3(CCCCCC3)C2=O)cc1

InChI Key InChIKey=QEOTVJLOGBZTPT-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350532   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350532(N-(4-bromophenyl)-2-(2,4-dioxo-1,3- diazaspiro[4.6...)
Affinity DataEC50:  679nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350532(N-(4-bromophenyl)-2-(2,4-dioxo-1,3- diazaspiro[4.6...)
Affinity DataEC50:  6.79E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent